Author:
Nishimura Rimei,Taniguchi Mayumi,Takeshima Tomomi,Iwasaki Kosuke
Funder
Dainippon Sumitomo Pharma
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference66 articles.
1. Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;2018(41):2669–701.
2. Araki E, Goto A, Kondo T, et al. Japanese clinical practice guideline for diabetes 2019. Diabetol Int. 2020;11:165–223.
3. Odawara M, Kawamori R, Tajima N, et al. Long-term treatment study of global standard dose metformin in Japanese patients with type 2 diabetes mellitus. Diabetol Int. 2017;8:286–95.
4. Kameda T, Kumamaru H, Nishimura S, Kohsaka S, Miyata H. Use of oral antidiabetic drugs in Japanese working-age patients with type 2 diabetes mellitus: dosing pattern for metformin initiators. Curr Med Res Opin. 2020;36:749–56.
5. Tamura Y, Kato H, Hiroi S, et al. A study on the prescription status of metformin and DPP-4 inhibitors in patients with type 2 diabetes mellitus in Japan. An analysis of data from health insurance administrative claims. Ther Res. 2017;38:1231–7 (Japanese).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献